PCN181 Real-World Evidence (RWE) in Reimbursement, Pricing, and Health Technology Assessment (HTA) in ASIA. How CAN Rwe Supplement Trial DATA in Oncology Indications in a Premarketing Setting?
Abstract
Authors
N. Schoenherr A. Brogan G.J. Outteridge J. Patel Zaballos MT Perez S. Bobiak